Cargando…
Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?
The antiphospholipid syndrome (APS) is characterized by the development of venous and/or arterial thrombosis and pregnancy morbidity in patients with persistent antiphospholipid antibodies (aPL). Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening form of APS occurring in about 1% of...
Autores principales: | Mormile, Ilaria, Granata, Francescopaolo, Punziano, Alessandra, de Paulis, Amato, Rossi, Francesca Wanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911562/ https://www.ncbi.nlm.nih.gov/pubmed/33535377 http://dx.doi.org/10.3390/biomedicines9020132 |
Ejemplares similares
-
Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center
por: Mormile, Ilaria, et al.
Publicado: (2021) -
The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship?
por: Mormile, Ilaria, et al.
Publicado: (2021) -
Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus
por: Mormile, Ilaria, et al.
Publicado: (2022) -
Radiological patterns and pulmonary function values of lung involvement in primary Sjögren’s syndrome: A pilot analysis
por: Mormile, Ilaria, et al.
Publicado: (2022) -
Functional Modulation of Human Macrophages by Secreted Phospholipases A(2): Implications in Cancer
por: Galdiero, Maria Rosaria, et al.
Publicado: (2022)